Статья

SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19

A. Tsatsakis, D. Calina, L. Falzone, D. Petrakis, R. Mitrut, V. Siokas, M. Pennisi, G. Lanza, M. Libra, S. Doukas, P. Doukas, L. Kavali, A. Bukhari, C. Gadiparthi, D. Vageli, D. Kofteridis, D. Spandidos, M. Paoliello, M. Aschner, A. Docea,
2021

Common manifestations of COVID-19 are respiratory and can extend from mild symptoms to severe acute respiratory distress. The severity of the illness can also extend from mild disease to life-threatening acute respiratory distress syndrome (ARDS). SARS-CoV-2 infection can also affect the gastrointestinal tract, liver and pancreatic functions, leading to gastrointestinal symptoms. Moreover, SARS-CoV-2 can cause central and peripheral neurological manifestations, affect the cardiovascular system and promote renal dysfunction. Epidemiological data have indicated that cancer patients are at a higher risk of contracting the SARS-CoV-2 virus. Considering the multitude of clinical symptoms of COVID-19, the objective of the present review was to summarize their pathophysiology in previously healthy patients, as well as in those with comorbidities. The present review summarizes the current, though admittedly fluid knowledge on the pathophysiology and symptoms of COVID-19 infection. Although unclear issues still remain, the present study contributes to a more complete understanding of the disease, and may drive the direction of new research. The recognition of the severity of the clinical symptoms of COVID-19 is crucial for the specific therapeutic management of affected patients. © 2020 Elsevier Ltd

Цитирование

Похожие публикации

Документы

Источник

Версии

  • 1. Version of Record от 2021-04-27

Метаданные

Об авторах
  • A. Tsatsakis
    Department of Forensic Sciences and Toxicology, Faculty of Medicine, University of Crete, Heraklion, 71003, Greece
  • D. Calina
    I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, 119146, Russian Federation
  • L. Falzone
    Department of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, Craiova, 200349, Romania
  • D. Petrakis
    Epidemiology Unit, IRCCS Istituto Nazionale Tumori “Fondazione G. Pascale”, Naples, 80131, Italy
  • R. Mitrut
    Department of Cardiology, University and Emergency Hospital, Bucharest, 050098, Romania
  • V. Siokas
    Department of Neurology, University of Thessaly, University Hospital of Larissa, Larissa, 41221, Greece
  • M. Pennisi
    Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, 95123, Italy
  • G. Lanza
    Department of Surgery and Medical-Surgical Specialties, University of Catania, Catania, 95123, Italy
  • M. Libra
    Department of Neurology IC, Oasi Research Institute-IRCCS, Troina, 94018, Italy
  • S. Doukas
    Research Center for Prevention, Diagnosis and Treatment of Cancer, University of Catania, Catania, 95123, Italy
  • P. Doukas
    Department of Internal Medicine, Saint Peter's University Hospital, 254 Easton Ave, New Brunswick, NJ 08901, United States
  • L. Kavali
    University of Pavol Josef Safarik University, Faculty of Medicine, Kosice, Slovakia
  • A. Bukhari
    Department of Medicine, Division of Pulmonary and Critical Care 240 Easton Ave, Adult Ambulatory at Cares Building 4th Floor, New Brunswick, NJ 08901, United States
  • C. Gadiparthi
    Division of Gastroenterology, Hepatology and Clinical Nutrition, Saint Peter's University Hospital, New Brunswick, NJ, United States
  • D. Vageli
    Department of Surgery, The Yale Larynx Laboratory, New Haven, CT 06510, United States
  • D. Kofteridis
    Department of Internal Medicine, University Hospital of Heraklion, Heraklion, Crete 71110, Greece
  • D. Spandidos
    Laboratory of Clinical Virology, Medical School, University of Crete, Heraklion, 71003, Greece
  • M. Paoliello
    Department of Molecular Pharmacology, Albert Eisntein College of Medicine, 1300 Morris Park Avenue BronxNY 10461, United States
  • M. Aschner
    Department of Toxicology, University of Medicine and Pharmacy of Craiova, Craiova, 200349, Romania
  • A. Docea
Название журнала
  • Food and Chemical Toxicology
Том
  • 146
Страницы
  • -
Ключевые слова
  • angiotensin converting enzyme 2; adult respiratory distress syndrome; Article; brain disease; cancer patient; cardiovascular system; cerebrovascular disease; coronary artery disease; coronavirus disease 2019; diabetes mellitus; disease severity; encephalitis; epilepsy; gastroenteritis; gastrointestinal disease; gastrointestinal tract; Guillain Barre syndrome; headache; heart failure; heart injury; hospital admission; human; hypertension; hypogeusia; hyposmia; kidney disease; malignant neoplasm; pandemic; pathophysiology; pneumonia; polyneuropathy; respiratory failure; respiratory system; Severe acute respiratory syndrome coronavirus 2; skin defect; smelling disorder; symptomatology; taste disorder; cardiovascular disease; comorbidity; complication; digestive system disease; drug therapy; female; kidney disease; lung disease; male; neoplasm; neurologic disease; pathophysiology; virology; Cardiovascular Diseases; Comorbidity; COVID-19; Digestive System Diseases; Female; Humans; Kidney Diseases; Lung Diseases; Male; Neoplasms; Nervous System Diseases; Pandemics; SARS-CoV-2
Издатель
  • Elsevier Ltd
Тип документа
  • journal article
Тип лицензии Creative Commons
  • CC
Правовой статус документа
  • Свободная лицензия
Источник
  • scopus